Clinical Trials
2 trialsNCT04370509 2025-11-19
Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery
University of California, San Francisco
Phase 2 Terminated
NCT05567588 2024-02-01
Pembrolizumab Plus Radiotherapy for Advanced Renal Cancer
Nanfang Hospital, Southern Medical University
Phase 2 Unknown